DnAFix project: DNA damage as a new biomarker for Atrial Fibrillation

Last year, AFIP published an article on the discovery made by the team of Prof. Bianca Brundel (Amsterdam UMC), that atrial fibrillation (AF) is associated with DNA damage in the heart. Therefore, a circulating oxidative DNA damage marker 8-hydroxy-2'-deoxyguanosine (8-OHdG) may represent a biomarker to stage AF and identify patients at risk for AF recurrence [...]
Jin Li, Amsterdam UMC

L-glutamine alters HSP levels and normalises energy status in patients with atrial fibrillation

Treatment strategies for atrial fibrillation (AF) are only moderately effective and do not prevent AF onset and progression. This difficulty of treatment predicts a great need to dissect root causes of AF and to develop novel therapies. Emerging research findings indicate that heat shock proteins (HSP) mitigate AF onset and progression in experimental model systems [...]
L Glutamine study results